BOBBY™ Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke
Key facts
- Who runs it
- Microvention-Terumo, Inc.
- Where
- Germany and Switzerland9 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 171 people enrolled
- Started
- 8 Apr 2022
- Ended
- 30 Dec 2023
- Type of study
- Observational
- Treatments tested
- BOBBY™ Balloon Guide Catheter intended for use in neurovascular procedures, performing or as an adjunctive device
- Record updated
- 7 January 2025
- Why it stopped
- endpoint reached
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Patient is ≥ 18 and ≤ 85 years of age
- Informed consent by the patient or legal authorized representative for data collection is obtained
- Patient eligible for the mechanical thrombectomy treatment with adjunctive use of the BOBBY™ BGC
- Patient presenting with an anterior circulation large-vessel occlusion of distal internal carotic artery (ICA ) through proximal M2 confirmed by computed tomograph angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA)
- Core-infarct volume of Alberta Stroke Program Early CT Score (ASPECTS) ≥ 6 based on baseline CT or MR imaging
- Treatment initiated (groin puncture) within 8 hours of symptom onset
- Patient with a pre-treatment National Institutes of Health Stroke Scale (NIHSS) score ≥5
- Patient with no personal condition disabling the site to contact him/her at 90 days after procedure
Who cannot take part
- Patient is already participating in an investigational drug or device trial (change routine care of the patient)
- Patient presents other serious medical illness (e.g., cancer) with estimated life expectancy of less than 3 months
- Patient has evidence of intracerebral hemorrhage on initial imaging
- Patient has evidence of cerebral ischemia in the posterior circulation
- Patient presents severe unilateral or bilateral carotid artery stenosis requiring stent treatment during the procedure
- Pregnancy or breastfeeding
- Patient has a planned procedure that may cause non-compliance with the protocol or confound data interpretation
- Patient has a significant mass effect with midline shift
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Evaluation of the safety and performance of the BOBBY™ Balloon Guide Catheter (BGC) in patients with an acute ischemic stroke treatment, a sudden reduction or termination of the blood circulation of the brain, caused by a clot. Immediate treatment is needed to restore the blood circulation in the brain, performing a mechanical removal of the clot (thrombectomy). To prevent clot particles migrating in other parts of the brain circulation during the thrombectomy, balloon guiding catheters are inserted. The aim of the study is to evaluate the safety and performance of the balloon guide catheter BOBBY™ by collecting information from patients, treated with a mechanical thrombectomy and the balloon guide catheter (BOBBY™) after acute ischemic stroke
The group in the trial
- single arm, observational post market study
Patients with an acute ischemic stroke with treatment including the BOBBY™ BGC
Treatment: BOBBY™ Balloon Guide Catheter intended for use in neurovascular procedures, performing or as an adjunctive device
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- STRAIT: Evaluation of Safety and Performance of the BOBBY™ Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke
- Publications
- Performance of the new generation BOBBY balloon guide catheter for endovascular treatment of acute ischemic stroke: results of the prospective, multicentric STRAIT study.Journal of neurointerventional surgery, 2026
- Record updated
- 7 January 2025